Predicted interactions involving protein CDC6, CDC18L: Cell division control protein 6 homolog (IPI00014575) that score above 12.5

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
CDC6 MCM2 MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 9.88E4 Evidence O
CDC6 CCNB2 CCNB2: G2/mitotic-specific cyclin-B2 1.59E4 Evidence
CDC6 MCM7 MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 1.59E4 Evidence
CDC6 CCNB1 Cyclin B1 7.89E3 Evidence
CDC6 MCM5 MCM5, CDC46: DNA replication licensing factor MCM5 7.47E3 Evidence
CDC6 ORC2L ORC2L, ORC2: Origin recognition complex subunit 2 4.51E3 Evidence O
CDC6 CDK2 CDK2: Cell division protein kinase 2 820.0 Evidence
CDC6 ORC4L ORC4L: Origin recognition complex subunit 4 594.0 Evidence
CDC6 ORC5L ORC5L: Origin recognition complex subunit 5 423.0 Evidence O
CDC6 MCM3 MCM3: DNA replication licensing factor MCM3 372.0 Evidence O
CDC6 MCM4 MCM4, CDC21: DNA replication licensing factor MCM4 372.0 Evidence
CDC6 PCNA PCNA: Proliferating cell nuclear antigen 226.0 Evidence O
CDC6 CKS1B CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 181.0 Evidence
CDC6 ORC1L ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 174.0 Evidence O
CDC6 BRCA2 BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein 71.40 Evidence
CDC6 MCM6 MCM6: DNA replication licensing factor MCM6 60.20 Evidence
CDC6 PSMC2 PSMC2, MSS1: 26S protease regulatory subunit 7 56.30 Evidence
CDC6 GTF2B GTF2B, TF2B, TFIIB: Transcription initiation factor IIB 51.50 Evidence
CDC6 RB1 RB1: Retinoblastoma-associated protein 49.60 Evidence
CDC6 BAZ1B BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain 46.90 Evidence
CDC6 BRCA1 BRCA1, RNF53: Breast cancer type 1 susceptibility protein 45.90 Evidence
CDC6 MYBL2 MYBL2, BMYB: Myb-related protein B 35.00 Evidence
CDC6 CDC7 CDC7, CDC7L1: Cell division cycle 7-related protein kinase 29.50 Evidence
CDC6 CDK4 CDK4: Cell division protein kinase 4 29.50 Evidence
CDC6 RFC5 RFC5: Replication factor C subunit 5 28.60 Evidence
CDC6 RFC3 RFC3: Replication factor C subunit 3 28.60 Evidence
CDC6 RFC4 RFC4: Replication factor C subunit 4 28.60 Evidence
CDC6 ORC6L ORC6L: Origin recognition complex subunit 6 28.2 Evidence O
CDC6 ESPL1 N/A 28.00 Evidence
CDC6 AKAP8 AKAP8, AKAP95: A-kinase anchor protein 8 26.00 Evidence
CDC6 VCP VCP: Transitional endoplasmic reticulum ATPase 25.10 Evidence
CDC6 CCNA2 CCNA2, CCN1, CCNA: Cyclin-A2 23.90 Evidence O
CDC6 RPA2 RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit 19.70 Evidence
CDC6 CCNF CCNF: G2/mitotic-specific cyclin-F 19.00 Evidence
CDC6 CCNH CCNH: Cyclin-H 18.90 Evidence
CDC6 MSH6 MSH6, GTBP: DNA mismatch repair protein MSH6 17.90 Evidence
CDC6 LIG1 LIG1: DNA ligase 1 17.90 Evidence
CDC6 PBK PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase 17.90 Evidence
CDC6 PKMYT1 PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito 17.80 Evidence
CDC6 SFRS1 SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 17.80 Evidence
CDC6 RBL1 RBL1: Retinoblastoma-like protein 1 17.60 Evidence
CDC6 PLK1 PLK1, PLK: Serine/threonine-protein kinase PLK1 17.10 Evidence
CDC6 RPA1 RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit 17.00 Evidence
CDC6 HMGN2 HMGN2, HMG17: Non-histone chromosomal protein HMG-17 16.10 Evidence
CDC6 CAD CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase 15.10 Evidence
CDC6 CCNE1 CCNE1, CCNE: G1/S-specific cyclin-E1 13.40 Evidence
CDC6 TAL1 TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 12.60 Evidence